Carmody RJ, Cotter TG (2001) Signalling apoptosis: a radical ap- proach. Redox Rep 6:77–90.
Cassarino DS, Parks JK, Parker WD Jr, Bennett JP Jr (1999) The
parkinsonian neurotoxin MPP opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta
1453:49 – 62.
Comelli M, Di Pancrazio F, Mavelli I (2003) Apoptosis is induced by
decline of mitochondrial ATP synthesis in erythroleukemia cells.
Free Radic Biol Med 34:1190 –1199.
Constantin D, Ala'Aldeent D, Murphy S (2002) Transcriptional activation of nitric oxide synthase-2, and NO-induced cell death, in
mouse cerebrovascular endothelium exposed to Neisseria meningitides. J Neurochem 81:270 –276.
Cosi C, Marien M (1998) Decreases in mouse brain NAD and ATP
induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP):
prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Brain Res 809:58 – 67.
Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302:819 – 822.
Denton T, Howard BD (1987) A dopaminergic cell line variant resistant
to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
J Neurochem 49:622– 630.
Desmet KD, Paz DA, Corry JJ, Eells JT, Wong-Riley MT, Henry MM,
Buchmann EV, Connelly MP, Dovi JV, Liang HL, Henshel DS,
Yeager RL, Millsap DS, Lim J, Gould LJ, Das R, Jett M, Hodgson
BD, Margolis D, Whelan HT (2006) Clinical and experimental ap- plications of NIR-LED photobiomodulation. Photomed Laser Surg
24:121–128.
Eells JT, Henry MM, Summerfelt P, Wong-Riley MTT, Buchmann EV,
Kane M, Whelan NT, Whelan HT (2003) Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc Natl Acad
Sci U S A 100:3439 –3444.
Eells JT, Wong-Riley MT, VerHoeve J, Henry M, Buchman EV, Kane
MP, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT
(2004) Mitochondrial signal transduction in accelerated wound and
retinal healing by near-infrared light therapy. Special issue on
mitochondrial medicine-developing the scientific basis to medical
management of mitochondrial disease. RK Naviaux (guest ed).
Mitochondrion 4:559 –568.
Gahm C, Holmin S, Wiklund PN, Brundin L, Mathiesen T (2006)
Neuroprotection by selective inhibition of inducible nitric oxide
synthase after experimental brain contusion. J Neurotrauma
23:1343–1354.
Hirata Y, Nagatsu T (2005) Rotenone and CCCP inhibit tyrosine
hydroxylation in rat striatal tissue slices. Toxicology 216:9 –14.
Hirsch EC, Faucheux B, Damier P, Mouatt-Prigent A, Agid Y (1997)
Neuronal vulnerability in Parkinson's disease. J Neural Transm
Suppl 50:79 – 88.
Hiura TS, Li N, Kaplan R, Horwitz M, Seagrave JC, Nel AE (2000) The
role of a mitochondrial pathway in the induction of apoptosis by
chemicals extracted from diesel exhaust particles. J Immunol
165:2703–2711.
Imamura K, Takeshima T, Kashiwaya Y, Nakaso K, Nakashima K
(2006) D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y
cells in a rotenone model of Parkinson's disease. J Neurosci Res
84:1376 –1384.
Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonisminducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: up- take of the metabolite N-methyl-4-phenylpyridine by dopamine
neurons explains selective toxicity. Proc Natl Acad Sci U S A
82:2173–2177.
Karu T (1999) Primary and secondary mechanisms of action of visible
to near-IR radiation on cells. J Photochem Photobiol B 49:1–17.
Karu T, Pyatibrat LV, Afanasyeva NI (2005) Cellular effects of low
power laser therapy can be mediated by nitric oxide. Lasers Surg
Med 36:307–314.
